Full-Time

Director/Senior Director

Program Management

Confirmed live in the last 24 hours

Tango Therapeutics

Tango Therapeutics

51-200 employees

Develops targeted cancer therapies using synthetic lethality

Biotechnology
Healthcare

Expert

Boston, MA, USA

Category
Genomics
Public Health
Biology Lab & Research
Biology & Biotech
Required Skills
Risk Management

You match the following Tango Therapeutics's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • Bachelor's degree required
  • Minimum of 10 years of relevant biotech or pharmaceutical industry experience is required
  • Minimum of 3 years in a program management role required
  • Hands on experience in leading program management activities in early and/or full clinical development is required
  • Experience in at least one of the functions related to pharmaceutical development (e.g. Research, Regulatory Affairs, Clinical Dev/Operations, CMC) is required
  • Must demonstrate good leadership and team building skills, ability to influence cross-functionally, work with different personalities and styles and maintain positive interpersonal relationships
  • Excellent written and verbal communication are essential, with the ability to clearly present and communicate complex program information in both formal and informal settings
  • Strong conflict resolution and problem-solving skills with an ability to handle complexity and ambiguity
  • Knowledge of project management tools and software (MS Project, etc.)
Responsibilities
  • Leads program management activities for one or more small molecule cancer therapeutics through development candidate selection to clinical Proof of Concept (POC) and into full development and registration
  • Supports the PL and the discovery program team in the development of the program strategy for selection of the development candidate (DC) and progression into clinical development by planning and tracking activities in lead optimization, pharmacology, toxicology and ADME studies, preclinical work for patient selection and indication expansion, drug supply and formulation development and clinical planning and operations
  • Guides the development team through clinical development by creating and executing on an integrated clinical plan for POC and registration
  • Develops and assesses different scenarios for accelerated approval based on clinical outcomes from the first in human studies of the single agent and its combination with other targeted therapies
  • Works with sub-teams in manufacturing, clinical operations, safety, translational biology, regulatory and commercial to ensure that functional activities are fully integrated into the clinical development plan and support indication expansion and regulatory approval
  • Achieves organizational alignment and seamless execution of the integrated drug discovery and development plans by working cross-functionally within Tango and with CROs
  • Defines critical path, at-risk activities, and inter-dependencies
  • Anticipates bottlenecks, clears barriers to progress program level scenario planning & risk management
  • Represents, as needed, the program team to discussions with leadership teams, scientific founders, and Directors
  • Tracks program progress against the plan, working with department heads to identify and resolve resource constraints consistent with corporate priorities
  • Supports active portfolio management (budget, resources, stage-gates) and decision-making and monitors progress of portfolio/program strategy, goals, and metrics
  • Establishes, together with the PL, program and individual goals that are aligned with corporate goals
  • Schedules, facilitates, and documents Program Team and ad-hoc program meetings; ensures uniformity between programs including agendas, meeting minutes and other program documentation
  • Identifies, tracks, and supports resolution efforts for all program-related issues
  • Relays positive and negative deviations from program plans to the program team and management
  • Facilitates resolution of conflicts between functional groups while maintaining objectivity
  • Ensures high-performing project teams by monitoring and assessing team effectiveness at both team and individual levels
  • Additional duties and responsibilities as required
Desired Qualifications
  • Experience in oncology development is preferred
  • Experience with Risk Management and Contingency Planning preferred
  • Experience setting and maintaining budgets preferred
  • PMP certification a plus

Tango Therapeutics develops targeted cancer treatments using the principle of synthetic lethality, which allows them to design drugs that kill cancer cells while leaving healthy cells unharmed. Their approach focuses on the interaction between genes, where the loss of both genes leads to cell death, but the loss of just one does not. This method enables them to create more effective therapies for cancer patients. Tango operates in the oncology market, primarily serving healthcare providers and pharmaceutical companies. They collaborate with larger firms, like Gilead Sciences, to co-develop therapies, which helps them secure funding and speed up the development process. Their goal is to bring next-generation targeted immunotherapies to market, supported by a strong team and strategic partnerships.

Company Stage

IPO

Total Funding

$341.4M

Headquarters

Cambridge, Massachusetts

Founded

2017

Growth & Insights
Headcount

6 month growth

1%

1 year growth

2%

2 year growth

10%
Simplify Jobs

Simplify's Take

What believers are saying

  • FDA's support for precision medicine could expedite Tango's regulatory approvals.
  • Advancements in CRISPR enhance development of synthetic lethality-based therapies.
  • Growing interest in synthetic lethality boosts Tango's market potential.

What critics are saying

  • Discontinuation of TNG348 due to liver toxicity may impact investor confidence.
  • Reliance on partnerships poses risks if collaborations are altered or terminated.
  • Intensifying competition in precision oncology could affect Tango's market share.

What makes Tango Therapeutics unique

  • Tango leverages synthetic lethality to target cancer cells while sparing healthy ones.
  • Their focus includes counteracting tumor suppressor gene loss and immune evasion.
  • Strategic collaborations with pharma giants like Gilead accelerate drug development.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Hybrid Work Options